The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Jacek Legutko

Showing 1-8 of 8 articles
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study
Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R
October 23, 2020 | 10.4244/EIJ-D-19-00361
First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold
Kochman J, Kołtowski Ł, Tomaniak M, Jąkała J, Proniewska K, Legutko J, Roleder T, Piertrasik A, Rdzanek A, Kochman W, Brugaletta S, Opolski G, Regar E
April 6, 2018 | 10.4244/EIJ-D-17-00311
Coronary interventions
Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry
Siudak Z, Tokarek T, Dziewierz A, Wysocki T, Wiktorowicz A, Legutko J, Zmudka K, Dudek D
September 20, 2017 | 10.4244/EIJ-D-17-00078
Coronary interventions
Poland: coronary and structural heart interventions from 2010 to 2015
Legutko J, Siudak Z, Parma R, Ochała A, Dudek D
May 15, 2017 | 10.4244/EIJ-D-16-00836
Coronary interventions
IVUS in bifurcation stenting: what have we learned?
Legutko J, Yamawaki M, Costa R, Costa M
May 19, 2015 | 10.4244/EIJV11SVA12
Mesh covered stent in ST-segment elevation myocardial infarction
Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski T, Bartus S, Dragan J, Klecha A, Lansky A, Siudak Z, Zmudka K
November 15, 2010
Time-to-reperfusion therapy influences outcome of patients with myocardial infarction subjected to facilitated PCI
Dudek D, Dziewierz A, Rakowski T, El Masri N, Sorysz D, Zalewski J, Legutko J, Zmudka K, Piwowarska W, Dubiel J
November 20, 2005
Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina
Dudek D, Heba G, Legutko J, Chyrchel M, Rakowski T, Kaluza G, Dubiel J
November 20, 2005

Latest news

NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021
NEW
Ahead of Print: OCT findings in ESR
Jincheng Guo et al.
February 24, 2021
Editorial
Consolidating the value of the standardised ARC-HBR definition
Giuseppe Gargiulo et al.
February 24, 2021
SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH
(Thanks to the support of Biotronik)
February 28, 2021
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
JAA
This weeks JAA's: IVUS Guidewire Locations During Retrograde CTO, TF-TAVI endovascular closing and more..
February 16, 2021
NEW
The Year in Review
M. Lunardi et al.
January 22, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke